Related references
Note: Only part of the references are listed.Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
Markus Mandler et al.
ACTA NEUROPATHOLOGICA (2014)
Alpha-Synuclein Transfers from Neurons to Oligodendrocytes
Juan F. Reyes et al.
GLIA (2014)
Antidepressants Reduce Neuroinflammatory Responses and Astroglial Alpha-Synuclein Accumulation in a Transgenic Mouse Model of Multiple System Atrophy
Elvira Valera et al.
GLIA (2014)
Alpha-synuclein mRNA expression in oligodendrocytes in MSA
Yasmine T. Asi et al.
GLIA (2014)
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
Dora Games et al.
JOURNAL OF NEUROSCIENCE (2014)
ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
Brian Spencer et al.
MOLECULAR THERAPY (2014)
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
Hien T. Tran et al.
CELL REPORTS (2014)
The Role of Glia in Alpha-Synucleinopathies
Lisa Fellner et al.
MOLECULAR NEUROBIOLOGY (2013)
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Elvira Valera et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Transmission of multiple system atrophy prions to transgenic mice
Joel C. Watts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THY-Tau22 Mouse Model: A Suitable Therapeutic Approach
Laetitia Troquier et al.
CURRENT ALZHEIMER RESEARCH (2012)
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy
Kiren Ubhi et al.
EXPERIMENTAL NEUROLOGY (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
Neuropathology and pathophysiology of multiple system atrophy
K. A. Jellinger
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy
Edward Rockenstein et al.
NEUROREPORT (2012)
Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo
Elodie Angot et al.
PLOS ONE (2012)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
He-Jin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Vaccination for Parkinson's disease
A. Schneeberger et al.
PARKINSONISM & RELATED DISORDERS (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
AFFITOME® technology in neurodegenerative diseases The doubling advantage
Achim Schneeberger et al.
HUMAN VACCINES (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Kiren Ubhi et al.
JOURNAL OF NEUROSCIENCE (2010)
Cell-to-cell transmission of non-prion protein aggregates
Seung-Jae Lee et al.
NATURE REVIEWS NEUROLOGY (2010)
Alpha-synuclein stimulation of astrocytes Potential role for neuroinflammation and neuroprotection
He-Jin Lee et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
Leslie Crews et al.
PLOS ONE (2010)
Vaccination with Aβ-Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral Aβ and Lowers Plaque Burden in APP Transgenic Mice
Patricia Bach et al.
JOURNAL OF IMMUNOLOGY (2009)
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2009)
Dissecting the potential molecular mechanisms underlying a-synuclein cell-to-cell transfer in Parkinson's disease
Elodie Angot et al.
PARKINSONISM & RELATED DISORDERS (2009)
Clearance and deposition of extracellular α-synuclein aggregates in microglia
He-Jin Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Origins and effects of extracellular alpha-synuclein: Implications in Parkinson's disease
Seung-Jae Lee
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Active immunization against Alzheimer's β-amyloid peptide using phage display technology
Beka Solomon
VACCINE (2007)
Effect of 4-hydroxy-2-nonenal modification α-synuclein aggregation
Zhijie Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Clinicopathological aspects of motor parkinsonism
Glenda Halliday
PARKINSONISM & RELATED DISORDERS (2007)
Neurological and neurodegenerative alterations in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter:: Implications for multiple system atrophy
CW Shults et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Anti-inflammatory properties of pro-inflummatory interferon-γ
H Mühl et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotype
TW Miller et al.
MOLECULAR THERAPY (2003)
Progress towards a vaccine for Huntington's disease
R Luthi-Carter
MOLECULAR THERAPY (2003)
Immunization delays the onset of prion disease in mice
EM Sigurdsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)